Sarepta Therapeutics’ stock falls after patient dies of liver failure

8 months ago 36
ARTICLE AD BOX
The company said that more than 800 people have been treated with Elevidys, with only one experiencing liver failure.
Read Entire Article
  1. Homepage
  2. Finance
  3. Sarepta Therapeutics’ stock falls after patient dies of liver failure

Related

Trump’s One Big Beautiful Bill Act will really kick into gear next year. These are the stocks to watch, says SocGen.

Trump’s One Big Beautiful Bill Act will really kick into gea...

30 minutes ago 0
‘I’m burned out by the drama’: Is it wrong to skip my Thanksgiving family dinner? Last year was fraught.

‘I’m burned out by the drama’: Is it wrong to skip my Thanks...

1 hour ago 0
Beaten-down Puma shares are soaring. The sportswear maker may have a suitor.

Beaten-down Puma shares are soaring. The sportswear maker ma...

1 hour ago 1

Trending

1. bengals vs ravens
2. ban vs ire
3. nbc
4. mike tomlin
5. emily compagno
6. scooter braun
7. miss international 2025
8. giant thanksgiving hours
9. casino
10. football today

Popular

Can Pidcock win big & why did it end at Ineos?

Can Pidcock win big & why did it end at Ineos?

8 months ago 390
Netflix scuttles plans to add six previously announced games to its service

Netflix scuttles plans to add six previously announced games...

9 months ago 346
‘I didn’t want to spend time with my children. I was just going through the motions’: the pain of parental burnout

‘I didn’t want to spend time with my children. I was just go...

9 months ago 340
‘Slanted’ Review: Extreme Makeover Satire Critiques Lopsided Beauty Standards Through Asian Eyes

‘Slanted’ Review: Extreme Makeover Satire Critiques Lopsided...

8 months ago 320
OpenAI co-founder John Schulman has left Anthropic after less than a year

OpenAI co-founder John Schulman has left Anthropic after les...

9 months ago 308
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Nexa News 2025. All rights are reserved